• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

I G Petrochemicals Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
500199
INE204A01010
428.8037935
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IGPL
58.2
1347.74
EPS(TTM)
Face Value()
Div & Yield %
7.52
10
1.14
 

acs technologies ltd
Bafna Pharmaceuticals standalone net profit rises 109.92% in the March 2026 quarter
May 30,2026
Net profit of Bafna Pharmaceuticals rose 109.92% to Rs 2.75 crore in the quarter ended March 2026 as against Rs 1.31 crore during the previous quarter ended March 2025. Sales rose 8.14% to Rs 42.24 crore in the quarter ended March 2026 as against Rs 39.06 crore during the previous quarter ended March 2025.

For the full year,net profit rose 167.47% to Rs 11.10 crore in the year ended March 2026 as against Rs 4.15 crore during the previous year ended March 2025. Sales rose 3.26% to Rs 150.62 crore in the year ended March 2026 as against Rs 145.86 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales42.2439.06 8 150.62145.86 3
OPM %8.407.96 -10.587.66 -
PBDT4.283.32 29 17.0411.19 52
PBT2.623.10 -15 10.976.30 74
NP2.751.31 110 11.104.15 167